Evidence map›Paper›PMID 35573904›Full record

ReviewFrontiers in artificial intelligence2022

A Unified Framework on Generalizability of Clinical Prediction Models.

Bohua Wan, Brian Caffo, S Swaroop Vedula

Abstract readReview
In one paragraph

Review in Frontiers in artificial intelligence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bohua WanDepartment of Computer Science, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, United States.
Brian CaffoDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
S Swaroop VedulaMalone Center for Engineering in Healthcare, Whiting School of Engineering, Baltimore, MD, United States.

Funding

TRD 4: Platforms for multi-modal and multi-scale imaging dataP41EB031771 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI Hanzhang Lu, Peter CM Van Zijl · 2021 to 2026
$9.9M
Statistical methods for structural and functional integration in multi-modal neuroimaging dataR01EB029977 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI CAFFO, BRIAN SCOTT · 2021 to 2024
$1.9M
NIBIB NIH HHS P41 EB031771NIBIB NIH HHS R01 EB029977
6 · The paper itself

Abstract

To be useful, clinical prediction models (CPMs) must be generalizable to patients in new settings. Evaluating generalizability of CPMs helps identify spurious relationships in data, provides insights on when they fail, and thus, improves the explainability of the CPMs. There are discontinuities in concepts related to generalizability of CPMs in the clinical research and machine learning domains. Specifically, conventional statistical reasons to explain poor generalizability such as inadequate model development for the purposes of generalizability, differences in coding of predictors and outcome between development and external datasets, measurement error, inability to measure some predictors, and missing data, all have differing and often complementary treatments, in the two domains. Much of the current machine learning literature on generalizability of CPMs is in terms of dataset shift of which several types have been described. However, little research exists to synthesize concepts in the two domains. Bridging this conceptual discontinuity in the context of CPMs can facilitate systematic development of CPMs and evaluation of their sensitivity to factors that affect generalizability. We survey generalizability and dataset shift in CPMs from both the clinical research and machine learning perspectives, and describe a unifying framework to analyze generalizability of CPMs and to explain their sensitivity to factors affecting it. Our framework leads to a set of signaling statements that can be used to characterize differences between datasets in terms of factors that affect generalizability of the CPMs.

Indexed as

clinical prediction modelsdataset shiftdiagnosisexplainabilityexternal validitygeneralizabilityprognosis

Identifiers

PMID35573904
PMCPMC9100692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.